Statistics on Biotechnology Use  
Results by fields of operation
Company sector.  Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production
Unidades: specified in variables

,Total,Main,Secondary dwellings,Tool,
Companies that carry out R&D in Biotechnology,1.198,644,171,383,
%Companies according to biotechnology used: Genetic code,33,3,40,9,24,24,8,
%Companies according to biotechnology used: Functional units,39,8,44,2,38,1,33,3,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,24,2,28,8,14,2,20,8,
%Companies according to biotechnology used: Bioprocesses,49,6,42,6,52,3,60,2,
%Companies according to biotechnology used: Sub-cellular organisms,6,7,8,7,5,8,3,6,
%Companies according to biotechnology used: Bio-computing,23,9,33,5,13,12,7,
%Companies according to biotechnology used: Nanobiotechnology,11,2,14,5,13,4,4,7,
%Companies according to biotechnology used: Other,14,6,14,4,19,9,12,6,
%Company by field(s) of ultimate application of biotechnology use: Human Health,47,3,62,8,35,1,26,7,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,19,4,21,7,17,8,16,2,
%Company by field(s) of ultimate application of biotechnology use: Food products,32,5,26,1,30,5,44,1,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,24,1,20,7,31,8,26,5,
%Company by field(s) of ultimate application of biotechnology use: Environment,14,9,12,8,28,9,12,3,
%Company by field(s) of ultimate application of biotechnology use: Industry,12,8,12,8,17,8,10,6,
Personnel in R&D in biotechnology (no. of persons),13.615,8.038,1.812,3.765,
Personnel in R&D in biotechnology (no. of persons): Researchers,7.436,4.561,1.031,1.845,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,6.178,3.477,781,1.920,
Personnel in R&D in biotechnology (no. of persons): women,7.639,4.718,918,2.003,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,4.095,2.582,540,973,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,3.544,2.136,378,1.030,
Personnel in R&D in biotechnology (FTE),9.365,2,5.985,1,1.120,4,2.259,7,
Personnel in R&D in biotechnology (FTE): Researchers,5.410,6,3.550,1,695,8,1.164,8,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,3.954,6,2.435,424,6,1.095,
Personnel in R&D in biotechnology (FTE): women,5.385,8,3.561,4,597,6,1.226,7,
Personnel in R&D in biotechnology (FTE): (women) Researchers,3.032,9,2.028,8,372,1,632,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,2.352,9,1.532,6,225,6,594,7,
Internal expenditure on R&D (thousands of euros),940.230,671.106,84.012,185.112,
1) By nature of the expense: Current expenses,871.813,624.784,75.356,171.672,
1.1) Remuneration to researchers,284.936,194.490,33.985,56.460,
1.2) Remuneration to technicians and assistants,148.254,96.140,14.239,37.875,
1.3) Other current expenses,438.623,334.154,27.132,77.337,
2) By nature of the expense: Capital expenses,68.417,46.322,8.656,13.440,
2.1) Land and buildings,11.763,6.204,2.874,2.685,
2.2) Equipment and instruments,39.641,24.588,5.378,9.674,
2.3) Acquisition of specific R+D software,2.831,1.735,319,777,
2.4) Otros productos de propiedad intelectual específicos para I+D,14.183,13.794,85,303,
1.1) By origin of the funds: Own funds,577.287,421.224,39.177,116.886,
1.2) By origin of the funds: From companies,142.672,96.993,8.211,37.467,
1.3) By origin of the funds: Public Administration funds,102.630,64.741,18.219,19.670,
1.4) By origin of the funds: From Universities,457,453,0,5,
1.5) By origin of the funds: From non profit private institutions,9.631,8.141,195,1.294,
1.6) By origin of the funds: Foreign funds,107.553,79.554,18.210,9.790,
Purchase of R&D services in biotechnology (thousands of euros),114.839,87.621,15.855,11.363,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,69.258,50.862,13.073,5.324,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,45.581,36.760,2.782,6.039,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,41,8,48,5,36,1,33,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,9,3,16,6,14,5,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,13,1,11,5,15,14,8,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,10,7,10,8,10,3,10,5,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets,15,16,15,14,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels,16,18,16,12,
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception,16,15,19,17,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,41,38,31,
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost,51,56,50,43,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,19,17,4,18,9,21,8,
% Companies that have requested biotechnology patents,18,26,14,8,
Number of patents requested,643,471,54,118,
% Companies with income of an international origin related to biotechnological activities,24,4,30,7,15,3,17,9,
% Turnover representing income of an international origin related to biotechnological activities,1,6,8,5,0,1,5,
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU,56,61,60,40,
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries,44,39,40,60,
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services,70,79,73,44,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,23,9,18,5,0,5,41,4,
% Income of an international origin related with activities according to the classification: Operating source abroad,5,3,1,9,26,7,14,5,
% Income of an international origin related with activities according to the classification: Other,0,6,0,8,0,0,1,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute